Welcome to the Anteo Diagnostics Limited (ASX:ADO) Investor Centre. This section is designed to give current and potential investors access to our important public information. We invite you to browse through our Investor Centre. If you don’t find the information you’re seeking, please contact us.
Welcome to our investor centre
- Our patented nanoglue technology is powerful and versatile. We are developing, producing and selling our healthcare nanoglue, Mix&Go™ in the life science markets, and working with partners to apply Mix&Go technology to improve diagnostic tests.
- Our technology has seen positive results regarding it’s application to battery manufacturing, and we continue to develop this drop in solution that has the potential to reduce the size, weight, cost and increase battery life.
- The application of our nanoglue is vast.
- The company has early stage revenues and strong partnerships developing with key pathology and medical device players.
- Our core nanoglue technology supported by a strong and expanding patent portfolio.
- Once the DIAsource acquisition is complete, Anteo will be transformed into a cash flow positive company.